Apatech

ApaTech is a medical technology company that specializes in the development of advanced synthetic bone graft substitutes. The company's core technology is based on silicate-substituted calcium phosphate (Si-CaP), which was developed to enhance the rate and quality of bone repair. Its flagship product, Actifuse, is widely used in spinal fusion and orthopedic surgeries as an osteoconductive scaffold that promotes bone growth. Founded as a spin-out from Queen Mary University of London, ApaTech grew into a global leader in the biomaterials market before being acquired by Baxter International in 2010. The company's products provide a reliable alternative to autograft and allograft procedures, reducing patient morbidity and improving surgical outcomes.